Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION

Last updated on 2023-03-29 History
Report ID 173394
Drug Identification Number 02242325
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name AMIODARONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3ML
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-02
Estimated end date 2023-01-27
Actual end date 2023-01-31
Shortage status Resolved
Updated date 2023-03-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2023-03-29 English Compare
v8 2023-02-01 English Compare
v7 2023-01-31 French Compare
v6 2023-01-31 English Compare
v5 2022-11-28 French Compare
v4 2022-11-28 English Compare
v3 2022-11-07 English Compare
v2 2022-11-02 French Compare
v1 2022-11-02 English Compare

Showing 1 to 9 of 9